Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Endocrine Therapy Against Locoregional Therapy First. A DBCG Trial in Postmenopausal Patients With Operable Hormone Receptor Positive Tumors Larger Than 2 cm.

NCT00908531 is registered in ClinicalTrials.gov with Danish Breast Cancer Cooperative Group as lead sponsor.

NCT NCT00908531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00908531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Endocrine Therapy Against Locoregional Therapy First. A DBCG Trial in Postmenopausal Patients With Operable Hormone Receptor Positive Tumors Larger Than 2 cm.
Lead sponsor
Danish Breast Cancer Cooperative Group
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2009
Completion date
December 1, 2013
Enrollment
123 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

operable breast neoplasms